Data compiled by Redley Lamar · ChainSifter Intelligence
2Suppliers
1Customers
3Debt Items
0Related Chains
Source-Backed Evidence Depth
Moleculin Biotech, Inc. (MBRX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
7Total relationships
1Distinct source URLs
6High confidence
0.853Average confidence
2026-09-14Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Moleculin Biotech, Inc. Suppliers
Ticker
Name
Confidence
Evidence
ANIMAL-LIFE-SCIENCES-INC
ANIMAL-LIFE-SCIENCES-INC
90%
In 2019, the Company sublicensed its technologies to Animal Life Sciences, Inc. (ALI), to enable research and commercialization for non-human use and share development data.
MD-ANDERSON
MD-ANDERSON
85%
The expenses recognized under the agreements were $ 212,000 and $ 211,000 for the three months ended March 31, 2026 and 2025 , respectively . The Company entered into a research agreement with MD And…
Moleculin Biotech, Inc. Customers
Ticker
Name
Confidence
Evidence
ROTH-CAPITAL-PARTNERS-LLC
ROTH-CAPITAL-PARTNERS-LLC
62%
rtain contingent settlement provision as liability warrants, initially measuring them at fair value on the date of issuance. The warrants were previously remeasured at fair value at the end of each r…
Moleculin Biotech, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
MBRX-DEBT-10882
Warrants outstanding: 107802
90%
xbrl warrant detail from xbrl 2025-12-31.
MBRX-DEBT-10883
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2018-12-31.
MBRX-DEBT
Debt stack $326,000
90%
Market cache reports total debt of $326,000.
Moleculin Biotech, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Moleculin Biotech, Inc..
Moleculin Biotech, Inc. Ownership
Holder
Name
Confidence
Evidence
MBRX-OWNER-MORGAN-STANLEY
MORGAN STANLEY
90%
13F overlay lists MORGAN STANLEY as top holder; 3 tracked holders.
Moleculin Biotech, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
